Concepedia

Michael Navitsky

MN

17

Publications

2.3K

Citations

14

H-Index

2011

Active since

Affiliations

Eli Lilly (United States)(Current)

Pennsylvania State University

Butler Hospital

University of Pennsylvania

Providence College

Michael Navitsky is an author at Eli Lilly (United States) specializing in medicine, neurology, and neurodegenerative diseases.

Top concepts

Publications per year

2011–2023

17

Publications

17

Regional profiles of the candidate tau PET ligand <sup>18</sup> F-AV-1451 recapitulate key features of Braak histopathological stages

Adam J. Schwarz, Peng Yu, Bradley B. Miller et al. · Brain · 2016 · 426 citations · Full text

Positron Emission Tomography Imaging With [<sup>18</sup>F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous et al. · JAMA Neurology · 2020 · 414 citations · Full text

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

Michael J. Pontecorvo, Michael D. Devous, Michael Navitsky et al. · Brain · 2017 · 356 citations · Full text

, , +21

A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia

Michael J. Pontecorvo, Michael D. Devous, Ian Kennedy et al. · Brain · 2019 · 239 citations · Full text

Tau Positron-Emission Tomography in Former National Football League Players

Robert A. Stern, Charles H. Adler, Kewei Chen et al. · New England Journal of Medicine · 2019 · 207 citations · Full text

Rows per page

1–5 of 17